Vanda Pharmaceuticals
VNDA
#7514
Rank
NZ$0.71 B
Marketcap
NZ$12.14
Share price
-0.83%
Change (1 day)
63.36%
Change (1 year)

EPS for Vanda Pharmaceuticals (VNDA)

EPS in 2025 (TTM): NZ-$2.43

According to Vanda Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$2.41. In 2024 the company made an earnings per share (EPS) of NZ-$0.54 a decrease over its 2023 EPS that were of NZ$0.08881.

EPS history for Vanda Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$2.43348.66%
2024NZ-$0.54-710.9%
2023NZ$0.08881-56.35%
2022NZ$0.20-80%
2021NZ$1.02
2019NZ$3.68334%
2018NZ$0.85-247.06%
2017NZ-$0.58-19.05%
2016NZ-$0.71-55.32%
2015NZ-$1.59-347.37%
2014NZ$0.64-156.72%
2013NZ-$1.14-31.63%
2012NZ-$1.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.89-884.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.21-607.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.31-195.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$39.04-1,721.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.39-614.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$5.87-343.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ-$7.44 209.15%๐Ÿ‡บ๐Ÿ‡ธ USA